Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

Journal of Cellular Biochemistry

Volumn 81, Issue 1, 2001, Pages 102-113

  Ariyoshi, Hideo ^a   Yoshikawa, Norihide ^a   Aono, Yasuhisa ^a   Tsuji, Yoshihisa ^a   Ueda, Atsushi ^a   Tokunaga, Masaru ^a   Sakon, Masato ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Advanced glycation end product; Captopril; Diabetic nephropathy; Oligodeoxynucleotide; Tyrosine phosphorylation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CAPTOPRIL; COLLAGEN; OLIGONUCLEOTIDE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; COLLAGEN SYNTHESIS; DIABETIC NEPHROPATHY; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; GLYCATION; KIDNEY FIBROSIS; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CAPTOPRIL; CELL LINE; COLLAGEN; DNA PRIMERS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; JANUS KINASE 2; KINETICS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TYROSINE; TYRPHOSTINS;

JANUS;

EID: 0035096603     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y     Document Type: Article

References (47)

1. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE
2. Mechanisms of disease: Transforming growth factor (beta) in tissue fibrosis
3. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone
4. STATs and gene regulation
5. Molecular insights into renal interstitial fibrosis
6. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts
7. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications
8. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition
9. Captopril reverses high glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor β receptor expressions
10. Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts
11. Effect of Advanced Glycation End Products on Lens Epithelial Cells in Vitro
12. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
13. Role of the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells
14. Type I collagen synthesis in cultured human fibroblasts: Regulation by cell spreading, platelet-derived growth factor and interactions with collagen fibers
15. Induction of the Ly-6A/E gene by interferon α/β and γ requires a DNA element to which a tyrosine phosphorylated 91-kDa protein binds
16. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
17. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials
18. Blockade of JAK2 by tyrphostin AG-490 inhibits antigen-induced eosinophil recruitment into the mouse airways
19. Diabetic nephropathy
20. An activator protein-1 (AP-1) response element on pro alpha1(1) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts
21. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group
22. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products
23. Growth-dependent modulation of type I collagen production and mRNA levels in cultured human skin fibroblasts
24. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: A cellular signal for hypertrophy in cardiac muscle
25. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
26. Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats
27. Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis
28. Use a mixture of proteinase free collagenases for the specific assay of radioactive collagen in the presence of other proteins
29. The paradox of the low-renin state in diabetic nephropathy
30. MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data
31. Cellular responses to interferons and other cytokines: The JAK-STAT paradigm
32. NF-κB inhibits expression of the alpha1(I) collagen gene
33. ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect
34. RAGE: A novel cellular receptor for advanced glycation end products
35. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1
36. Fibrous tissue and angiotensin II
37. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products
38. A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides
39. Angiotensin converting enzsyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts
40. Modulation of collagen gene expression: Its relation to fibrosis in systemic sclerosis and other disorders
41. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-κB activation
42. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
43. The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
44. Roles of the AGE-RAGE system in vascular injury in diabetes
45. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease
46. Interaction between high glucose and transforming growth factor-β in cell cycle protein regulations in MDCK cells
47. The renal tubulointerstitium in diabetes mellitus